Position in A
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$174,281,328
+$19,660,278 QoQ
Shares Held
1,312,063
-3.3% QoQ
Ownership
0.465%
of shares outstanding
% of Portfolio
2.35%
of 13F equity value
Holder Rank
#42
of 1,112 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in A Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Findlay Park Partners LLP holds $431,696,848 across 3 Diagnostics & Research names. A ranks #1 (40.4% of the industry book) .
All Filings in A
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $174,281,328 | 1,312,063 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $154,621,050 | 1,356,563 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $109,504,101 | 804,763 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $199,012,835 | 1,550,548 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $151,927,254 | 1,287,410 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $156,052,489 | 1,334,010 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $152,356,337 | 1,134,110 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $167,665,100 | 1,129,210 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $147,935,052 | 1,141,210 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $142,644,908 | 980,310 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $160,080,532 | 1,151,410 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $107,097,058 | 957,763 | Shares | Sole | 2023-11-07 | |
| 2021-03-31 | $121,015,284 | 951,827 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $298,470,740 | 2,518,953 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $376,001,500 | 3,725,000 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $364,526,250 | 4,125,000 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $322,290,000 | 4,500,000 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||